Old Web
English
Sign In
Acemap
>
Paper
>
The Design of Potent and Selective Inhibitors to Overcome Clinical Alk Mutations Resistant to Crizotinib.
The Design of Potent and Selective Inhibitors to Overcome Clinical Alk Mutations Resistant to Crizotinib.
2014
Qinhua Huang
Ted W. Johnson
Simon Bailey
Alexei Brooun
Kevin D. Bunker
Benjamin J. Burke
Michael Raymond Collins
Andrew S. Cook
Jean Cui
Kevin Neil Dack
Judith Gail Deal
Ya-Li Deng
Dac M. Dinh
Lars D. Engstrom
Mingying He
Jacqui Elizabeth Hoffman
Robert Louis Hoffman
Hong Shen
Patrick Stephen Johnson
Robert Steven Kania
Hieu Lam
Justine L. Lam
Phuong Thi Quy Le
Qiuhua Li
Laura Lingardo
Wei Liu
M West Lu
Michele McTigue
Cynthia Louise Palmer
Paul F. Richardson
Neal W. Sach
Tod Smeal
Graham L. Smith
Albert E. Stewart
Sergei Timofeevski
Konstantinos Tsaparikos
Hai Wang
Huichun Zhu
JinJiang Zhu
Helen Y. Zou
Martin Paul Edwards
Keywords:
Biochemistry
Chemistry
Cancer research
Crizotinib
Transferase
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]